Release date: 2007-05-29
Studies have shown that the prefilled syringe market will grow at a rate of 12.8% per year. Prefilled syringes are not a new technology. Most of the previous applications were widely used in the field of insulin and human auxin administration. According to a study by the US medical device and medical technology company Becton Dickinson and a consulting company, it is expected that the prefilled syringe market will grow at a rate of 12.8% per year. In 2006, the sales volume of prefilled syringes was about 1.4 billion. In 2010, sales are expected to exceed 2.4 billion.
It has several outstanding advantages: no cross infection during use, convenient use by medical staff, full use of some high-grade drugs, no residual liquid, suitable for self-injection in the field. Prefilled syringes are used in a wide range of applications, such as multiple sclerosis, infertility, osteoporosis, hepatitis, rheumatoid arthritis, cancer, anemia, and hemophilia. The patient's needs are the real driving force behind the development of prefilled syringes. It is a time-consuming task to take medicine from a vial into a syringe, and people who lack adequate training are prone to error. In addition, some diseases such as rheumatoid arthritis are often difficult, even unable to hold the vial and measure the exact dose.
Prefilled syringes can significantly reduce overfilling of the product. With a prefilled syringe, you can save 10%, 15%, and sometimes even 20% of the drug substance. Some manufacturers who have changed vials to prefilled syringes have also reduced the production of APIs because the new formulations no longer require as many APIs.
Studies have shown that the dose in a prefilled syringe can be 23% higher than a vial because there is less drug loss during transfer from the vial to the syringe.
â€”â€” Information from: Kexun Information Center
Super Absorbent Bath Mat,Bath Mat,Diatomite Health Hot Bath Mat,Non Slip Bath Mat
Dongguan Vanilla Bioengineering Co., Ltd. , https://www.healthecigarette.de